These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34638992)

  • 1. Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model.
    Apolloni S; Fabbrizio P; Amadio S; Napoli G; Freschi M; Sironi F; Pevarello P; Tarroni P; Liberati C; Bendotti C; Volonté C
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
    Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
    J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1
    Ruiz-Ruiz C; García-Magro N; Negredo P; Avendaño C; Bhattacharya A; Ceusters M; García AG
    Dis Model Mech; 2020 Oct; 13(10):. PubMed ID: 33174532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
    Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1
    Ly D; Dongol A; Cuthbertson P; Guy TV; Geraghty NJ; Sophocleous RA; Sin L; Turner BJ; Watson D; Yerbury JJ; Sluyter R
    Purinergic Signal; 2020 Mar; 16(1):109-122. PubMed ID: 32170537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia.
    Fabbrizio P; Amadio S; Apolloni S; Volonté C
    Front Cell Neurosci; 2017; 11():249. PubMed ID: 28871219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
    Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
    Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1
    Bartlett R; Sluyter V; Watson D; Sluyter R; Yerbury JJ
    PeerJ; 2017; 5():e3064. PubMed ID: 28265522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
    Bette M; Cors E; Kresse C; Schütz B
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.
    D'Ambrosi N; Finocchi P; Apolloni S; Cozzolino M; Ferri A; Padovano V; Pietrini G; Carrì MT; Volonté C
    J Immunol; 2009 Oct; 183(7):4648-56. PubMed ID: 19734218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.
    Bartlett R; Ly D; Cashman NR; Sluyter R; Yerbury JJ
    Purinergic Signal; 2022 Dec; 18(4):451-467. PubMed ID: 35478453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
    J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.